Home > Insider Trading > Filing (0001127602-20-031378)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1423221	Quanex Building Products Corp	NX	Rolling Drawing & Extruding Of Nonferrous Metals (3350)	261561397

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1550744	M. Scott Zuehlke	1800 West Loop South Suite 1500 Houston TX 77027	Senior Vp, Cfo & Treasurer	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2020-12-14	1,376	$0.00	26,541	No	4	A	Direct
Common Stock	Disposition	2020-12-14	336	$21.80	26,205	No	4	F	Direct
Common Stock	Acquisiton	2020-12-15	12,500	$17.46	38,705	No	4	M	Direct
Common Stock	Disposition	2020-12-15	12,500	$22.32	26,205	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	A	Direct
No	4	F	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Options (Right to Buy)	Disposition	2020-12-15	12,500	$0.00	12,500	$17.46

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0		2026-01-25	No	4	M	Direct

Footnotes

On December 7, 2017, the reporting person was granted a target number of performance restricted stock units, with a potential payout from 0% to 200% of target based on the Company's absolute total shareholder return over the three year period from November 1, 2017 through October 31, 2020. The payout amount was finalized on December 11, 2020, resulting in the issuance of common stock on December 14, 2020.
Shares were sold to cover taxes due in connection with the grant of common stock relating to the vesting of Performance Restricted Stock Units originally granted on December 7, 2017.
The price reported in Column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $21.89 to $22.55, inclusive. The reporting person undertakes to provide to NX, any security holder of NX, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
The options become exercisable in 1/3 increments annually beginning one year from the grant date.